INTERCOS SPA (ICOS.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:ICOS - IT0005455875 - Common Stock
11.54 EUR
+0.1 (+0.87%)
We assign a fundamental rating of 4 out of 10 to ICOS. ICOS was compared to 15 industry peers in the Personal Care Products industry. While ICOS seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, ICOS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year ICOS was profitable.
ICOS had a positive operating cash flow in the past year.
ICOS had positive earnings in each of the past 5 years.
Each year in the past 5 years ICOS had a positive operating cash flow.
1.2 Ratios
ICOS has a worse Return On Assets (4.71%) than 60.00% of its industry peers.
With a Return On Equity value of 10.16%, ICOS is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
ICOS has a Return On Invested Capital (9.59%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for ICOS is below the industry average of 11.66%.
The last Return On Invested Capital (9.59%) for ICOS is above the 3 year average (9.32%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.71% | ||
| ROE | 10.16% | ||
| ROIC | 9.59% |
ROA(3y)4.84%
ROA(5y)4.37%
ROE(3y)10.88%
ROE(5y)10.92%
ROIC(3y)9.32%
ROIC(5y)8.1%
1.3 Margins
ICOS's Profit Margin of 4.34% is on the low side compared to the rest of the industry. ICOS is outperformed by 60.00% of its industry peers.
In the last couple of years the Profit Margin of ICOS has declined.
ICOS has a Operating Margin of 9.31%. This is comparable to the rest of the industry: ICOS outperforms 46.67% of its industry peers.
In the last couple of years the Operating Margin of ICOS has declined.
Looking at the Gross Margin, with a value of 19.84%, ICOS is doing worse than 93.33% of the companies in the same industry.
In the last couple of years the Gross Margin of ICOS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.31% | ||
| PM (TTM) | 4.34% | ||
| GM | 19.84% |
OM growth 3Y-0.98%
OM growth 5Y-5.21%
PM growth 3Y4.42%
PM growth 5Y-5.47%
GM growth 3Y-3.29%
GM growth 5Y-3.96%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ICOS is creating some value.
Compared to 1 year ago, ICOS has about the same amount of shares outstanding.
ICOS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ICOS is higher compared to a year ago.
2.2 Solvency
ICOS has an Altman-Z score of 3.39. This indicates that ICOS is financially healthy and has little risk of bankruptcy at the moment.
ICOS's Altman-Z score of 3.39 is in line compared to the rest of the industry. ICOS outperforms 60.00% of its industry peers.
The Debt to FCF ratio of ICOS is 16.66, which is on the high side as it means it would take ICOS, 16.66 years of fcf income to pay off all of its debts.
ICOS's Debt to FCF ratio of 16.66 is on the low side compared to the rest of the industry. ICOS is outperformed by 86.67% of its industry peers.
A Debt/Equity ratio of 0.52 indicates that ICOS is somewhat dependend on debt financing.
ICOS has a Debt to Equity ratio (0.52) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 16.66 | ||
| Altman-Z | 3.39 |
ROIC/WACC1.44
WACC6.66%
2.3 Liquidity
ICOS has a Current Ratio of 1.67. This is a normal value and indicates that ICOS is financially healthy and should not expect problems in meeting its short term obligations.
ICOS has a Current ratio of 1.67. This is in the better half of the industry: ICOS outperforms 80.00% of its industry peers.
A Quick Ratio of 1.03 indicates that ICOS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.03, ICOS is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 4.80% over the past year.
Measured over the past 5 years, ICOS shows a small growth in Earnings Per Share. The EPS has been growing by 1.57% on average per year.
Looking at the last year, ICOS shows a quite strong growth in Revenue. The Revenue has grown by 9.02% in the last year.
Measured over the past years, ICOS shows a quite strong growth in Revenue. The Revenue has been growing by 8.36% on average per year.
EPS 1Y (TTM)4.8%
EPS 3Y20.17%
EPS 5Y1.57%
EPS Q2Q%-6.97%
Revenue 1Y (TTM)9.02%
Revenue growth 3Y16.49%
Revenue growth 5Y8.36%
Sales Q2Q%5%
3.2 Future
The Earnings Per Share is expected to grow by 11.78% on average over the next years. This is quite good.
Based on estimates for the next years, ICOS will show a small growth in Revenue. The Revenue will grow by 1.81% on average per year.
EPS Next Y4.62%
EPS Next 2Y11.05%
EPS Next 3Y11.78%
EPS Next 5YN/A
Revenue Next Year1.85%
Revenue Next 2Y3.77%
Revenue Next 3Y4.46%
Revenue Next 5Y1.81%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 23.55 indicates a rather expensive valuation of ICOS.
The rest of the industry has a similar Price/Earnings ratio as ICOS.
ICOS's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.31.
With a Price/Forward Earnings ratio of 14.78, ICOS is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ICOS indicates a somewhat cheap valuation: ICOS is cheaper than 73.33% of the companies listed in the same industry.
ICOS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.59.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.55 | ||
| Fwd PE | 14.78 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ICOS indicates a somewhat cheap valuation: ICOS is cheaper than 73.33% of the companies listed in the same industry.
ICOS's Price/Free Cash Flow ratio is rather expensive when compared to the industry. ICOS is more expensive than 86.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 70.99 | ||
| EV/EBITDA | 7.92 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ICOS does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)5.1
PEG (5Y)14.99
EPS Next 2Y11.05%
EPS Next 3Y11.78%
5. Dividend
5.1 Amount
ICOS has a Yearly Dividend Yield of 1.72%. Purely for dividend investing, there may be better candidates out there.
ICOS's Dividend Yield is comparable with the industry average which is at 2.90.
ICOS's Dividend Yield is slightly below the S&P500 average, which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.72% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
38.09% of the earnings are spent on dividend by ICOS. This is a low number and sustainable payout ratio.
DP38.09%
EPS Next 2Y11.05%
EPS Next 3Y11.78%
BIT:ICOS (11/28/2025, 7:00:00 PM)
11.54
+0.1 (+0.87%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners37.78%
Inst Owner ChangeN/A
Ins Owners32.17%
Ins Owner ChangeN/A
Market Cap1.11B
Revenue(TTM)1.09B
Net Income(TTM)47.30M
Analysts86.67
Price Target17.39 (50.69%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.72% |
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP38.09%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.07%
EPS NY rev (3m)-0.27%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.81%
Revenue NY rev (3m)-1.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.55 | ||
| Fwd PE | 14.78 | ||
| P/S | 1.02 | ||
| P/FCF | 70.99 | ||
| P/OCF | 12.43 | ||
| P/B | 2.39 | ||
| P/tB | 4.18 | ||
| EV/EBITDA | 7.92 |
EPS(TTM)0.49
EY4.25%
EPS(NY)0.78
Fwd EY6.77%
FCF(TTM)0.16
FCFY1.41%
OCF(TTM)0.93
OCFY8.05%
SpS11.31
BVpS4.83
TBVpS2.76
PEG (NY)5.1
PEG (5Y)14.99
Graham Number7.3
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.71% | ||
| ROE | 10.16% | ||
| ROCE | 14.65% | ||
| ROIC | 9.59% | ||
| ROICexc | 11.59% | ||
| ROICexgc | 17.27% | ||
| OM | 9.31% | ||
| PM (TTM) | 4.34% | ||
| GM | 19.84% | ||
| FCFM | 1.44% |
ROA(3y)4.84%
ROA(5y)4.37%
ROE(3y)10.88%
ROE(5y)10.92%
ROIC(3y)9.32%
ROIC(5y)8.1%
ROICexc(3y)12.89%
ROICexc(5y)11.65%
ROICexgc(3y)22.3%
ROICexgc(5y)20.57%
ROCE(3y)14.06%
ROCE(5y)12.06%
ROICexgc growth 3Y0.58%
ROICexgc growth 5Y-13.66%
ROICexc growth 3Y4.35%
ROICexc growth 5Y-9.88%
OM growth 3Y-0.98%
OM growth 5Y-5.21%
PM growth 3Y4.42%
PM growth 5Y-5.47%
GM growth 3Y-3.29%
GM growth 5Y-3.96%
F-Score7
Asset Turnover1.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 16.66 | ||
| Debt/EBITDA | 1.6 | ||
| Cap/Depr | 144.42% | ||
| Cap/Sales | 6.77% | ||
| Interest Coverage | 11.2 | ||
| Cash Conversion | 58.65% | ||
| Profit Quality | 33.11% | ||
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 3.39 |
F-Score7
WACC6.66%
ROIC/WACC1.44
Cap/Depr(3y)119.92%
Cap/Depr(5y)113.2%
Cap/Sales(3y)5.7%
Cap/Sales(5y)5.95%
Profit Quality(3y)77.95%
Profit Quality(5y)89.83%
High Growth Momentum
Growth
EPS 1Y (TTM)4.8%
EPS 3Y20.17%
EPS 5Y1.57%
EPS Q2Q%-6.97%
EPS Next Y4.62%
EPS Next 2Y11.05%
EPS Next 3Y11.78%
EPS Next 5YN/A
Revenue 1Y (TTM)9.02%
Revenue growth 3Y16.49%
Revenue growth 5Y8.36%
Sales Q2Q%5%
Revenue Next Year1.85%
Revenue Next 2Y3.77%
Revenue Next 3Y4.46%
Revenue Next 5Y1.81%
EBIT growth 1Y16.33%
EBIT growth 3Y15.34%
EBIT growth 5Y2.71%
EBIT Next Year72.17%
EBIT Next 3Y26.74%
EBIT Next 5YN/A
FCF growth 1Y-69.82%
FCF growth 3Y14.23%
FCF growth 5Y-3.11%
OCF growth 1Y-14.11%
OCF growth 3Y17%
OCF growth 5Y3.39%
INTERCOS SPA / ICOS.MI FAQ
What is the ChartMill fundamental rating of INTERCOS SPA (ICOS.MI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ICOS.MI.
What is the valuation status of INTERCOS SPA (ICOS.MI) stock?
ChartMill assigns a valuation rating of 3 / 10 to INTERCOS SPA (ICOS.MI). This can be considered as Overvalued.
How profitable is INTERCOS SPA (ICOS.MI) stock?
INTERCOS SPA (ICOS.MI) has a profitability rating of 3 / 10.
Can you provide the financial health for ICOS stock?
The financial health rating of INTERCOS SPA (ICOS.MI) is 4 / 10.
What is the expected EPS growth for INTERCOS SPA (ICOS.MI) stock?
The Earnings per Share (EPS) of INTERCOS SPA (ICOS.MI) is expected to grow by 4.62% in the next year.